These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 16499476

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sildenafil has little influence on cardiovascular hemodynamics or 6-km time trial performance in trained men and women at simulated high altitude.
    Jacobs KA, Kressler J, Stoutenberg M, Roos BA, Friedlander AL.
    High Alt Med Biol; 2011; 12(3):215-22. PubMed ID: 21962064
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
    Beidleman BA, Muza SR, Fulco CS, Cymerman A, Ditzler D, Stulz D, Staab JE, Skrinar GS, Lewis SF, Sawka MN.
    Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
    Carlsten C, Swenson ER, Ruoss S.
    High Alt Med Biol; 2004 Mar; 5(1):33-9. PubMed ID: 15072715
    [Abstract] [Full Text] [Related]

  • 10. Acetazolamide: a treatment for chronic mountain sickness.
    Richalet JP, Rivera M, Bouchet P, Chirinos E, Onnen I, Petitjean O, Bienvenu A, Lasne F, Moutereau S, León-Velarde F.
    Am J Respir Crit Care Med; 2005 Dec 01; 172(11):1427-33. PubMed ID: 16126936
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Effects of Acetazolamide on Exercise Performance at Sea Level and in Hypoxic Environments: A Review.
    Posch AM, Dandorf S, Hile DC.
    Wilderness Environ Med; 2018 Dec 01; 29(4):541-545. PubMed ID: 30314664
    [Abstract] [Full Text] [Related]

  • 13. Acetazolamide does not alter endurance exercise performance at 3,500-m altitude.
    Bradbury KE, Yurkevicius BR, Mitchell KM, Coffman KE, Salgado RM, Fulco CS, Kenefick RW, Charkoudian N.
    J Appl Physiol (1985); 2020 Feb 01; 128(2):390-396. PubMed ID: 31804890
    [Abstract] [Full Text] [Related]

  • 14. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM.
    Arch Intern Med; 2005 Feb 14; 165(3):296-301. PubMed ID: 15710792
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
    Bernhard WN, Schalick LM, Delaney PA, Bernhard TM, Barnas GM.
    Aviat Space Environ Med; 1998 Sep 14; 69(9):883-6. PubMed ID: 9737760
    [Abstract] [Full Text] [Related]

  • 17. Effects of acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitudes.
    Faoro V, Huez S, Giltaire S, Pavelescu A, van Osta A, Moraine JJ, Guenard H, Martinot JB, Naeije R.
    J Appl Physiol (1985); 2007 Oct 14; 103(4):1161-5. PubMed ID: 17615281
    [Abstract] [Full Text] [Related]

  • 18. Seven intermittent exposures to altitude improves exercise performance at 4300 m.
    Beidleman BA, Muza SR, Fulco CS, Cymerman A, Sawka MN, Lewis SF, Skrinar GS.
    Med Sci Sports Exerc; 2008 Jan 14; 40(1):141-8. PubMed ID: 18091011
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.